Skip to content

Sections
- Health
- Pharma
- Biotech
- Hospitals
- Politics
- In the Lab
- First Opinion
- Gut Check
- The Watchdogs
Topics
Multimedia
Popular
STAT Plus

Job Board
About Us

Newsletters
My Account
- Settings
- Log Out

Newsletters
My Account
- Settings
- Log Out

Reporting from the frontiers of health and medicine

Hospitals

A $200 million gift promotes alternative therapies at a California medical school — and critics recoil

By Usha Lee McFarling

Opinions Plus

Doctors, beware: Prosecutors are zooming in on health care fraud as opioid crisis mounts

By Robert M. Thomas Jr.

Politics

Under GOP health care bill, states would struggle to hang onto Obamacare

By Erin Mershon

Biotech The Biotech Devil’s Dictionary: Your guide to the inanities of industry jargon
Politics In Congress, a doctor becomes a cancer patient — and preaches candor
First Opinion Boosting competition among hospitals, health systems will improve health care
Health Educational event or swag-fest? Addiction treatment companies chase business with flashy giveaways
The Pharmalot View This pharma CEO won praise for his ‘social contract’ with the public. But his latest move could shred that pledge

Dozens of states probe role of drug makers and distributors in the opioid crisis
Some drugs that are heavily promoted to doctors may not be worth it
Brand-name drug prices are still rising, just not as fast as before

advertisement

Follow Us

Health

‘Every time it’s a battle’: In excruciating pain, sickle cell patients are shunted aside

By Sharon Begley

Heavyweights

Did he really just tweet that? Dr. Vinay Prasad takes on Big Pharma, Big Medicine, and his own colleagues — with glee

By Meghana Keshavan

A STAT Investigation

IBM pitched its Watson supercomputer as a revolution in cancer care. It’s nowhere close

By Casey Ross and Ike Swetlitz

Pharma

Pharma’s five favorite tricks to protect a monopoly

By Damian Garde

Health

A surgeon’s secret: As she operated on babies’ birth defects, a doctor hid her own diagnosis

By Charlotte Huff

A STAT Investigation IBM pitched its Watson supercomputer as a revolution in cancer care. It’s nowhere close
Heavyweights Did he really just tweet that? Dr. Vinay Prasad takes on Big Pharma, Big Medicine, and his own colleagues — with glee
The Pharmalot View This pharma CEO won praise for his ‘social contract’ with the public. But his latest move could shred that pledge
State of (Trump's) Mind Trump wasn’t always so linguistically challenged. What could explain the change?
Health New on the streets: Gabapentin, a drug for nerve pain, and a new target of misuse

All Popular Stories

By Megan Thielking

Get ahead of the day's health and medicine news with our Morning Rounds newsletter.

Please enter a valid email address.

Video

VIDEO: This is why science loves twins

By Jeffery DelViscio and Thomas DelViscio

In the Lab

WATCH: A race to the US to save a newborn’s eyesight

By Fan Bu and Melody Cao

In the Lab

Inside a DEA drug lab, a race to identify dangerous new opioids

Health

Climate change: It’s the mother of all human health issues

By Jeffery DelViscio and Dominic Smith

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

Industry

Sign up for our morning rounds newsletter

Reporting from the frontiers of health and medicine

About Us
Contact Us
The STAT Team
Work at STAT
Job Board
Advertise

Privacy
Comment Policy
Terms

© 2017 STAT

X